Fujifilm launches a more comprehensive portfolio for Europe's healthcare community following the integration of Hitachi Diagnostic Imaging
Düsseldorf, July 01, 2021 (GLOBE NEWSWIRE) -- Today at a virtual European event, the newly named FUJIFILM Healthcare Europe and FUJIFILM Europe’s existing European medical business (hereinafter referred to as “Fujifilm”) presented a complete and integrated portfolio of diagnostic products and services, including CT, MRI, X-ray, AI, PACS, endoscopy and ultrasound systems. Today's launch follows the completion of Fujifilm's acquisition and takeover of Hitachi's Diagnostic Imaging-related business on 31 March 2021 for 179 billion yen (€1.3 billion), with the newly named FUJIFILM Healthcare Europe also launching today.
Presenting a more comprehensive portfolio to an audience of key opinion leaders in the medical community, customers and the media, the synergy of FUJIFILM Healthcare Europe and Fujifilm is central to the growth strategy of the Japanese multinational in Europe, as Fujifilm looks to establish itself as a healthcare market leader. Combining the two organisations’ product line-ups enhances Fujifilm's overall capability to offer a comprehensive solution that caters to a broad range of clinical needs.
As a result of this strengthened offer, Fujifilm intends to significantly expand its diagnostics business globally as one of the Group's leading growth drivers, aiming to achieve a turnover of 860 billion yen (€6.6 billion) within the next three years; a growth of more than 50% compared to the fiscal year ending March 2020.
Today's virtual event presented the European medical community with a comprehensive healthcare portfolio. FUJIFILM Healthcare Europe's expertise in CT, MRI and ultrasound, combined with Fujifilm’s business’ core capabilities in x-ray, endoscopy, women's health, AI, PACS and IVD, allow the company to maximise its services and products in several areas of prevention and diagnosis for the benefit of patients in Europe.
Highlights of the enhanced portfolio that demonstrate this new strength include:
1) FUJIFILM Healthcare Europe's high-image-quality and robust CT combined with Fujifilm’s AI technology platform REiLI, and SYNAPSE 3D, which supports post-processing, offering a low dose solution to radiology departments and total support from imaging to diagnosis.
2) An enhanced Fujifilm offering to a wider range of hospital departments, including gynaecology, surgery and urology. For example, the clinical application of FUJIFILM Healthcare Europe's ultrasound technology in surgery provides a platform for Fujifilm’s new introduction of surgical endoscopes and SYNAPSE 3D.
3) Expanded application and technical support and service across the complete portfolio of Fujifilm medical products.
"We have worked hard to achieve this important milestone for Fujifilm and its future development. Today we are stronger together, and our goal is to maximise these new comprehensive and complete portfolio synergies. Our goal is to position ourselves as a market leader and number one comprehensive partner for the Healthcare community in Europe in the field of prevention and diagnosis," says Toshi Iida, President and Managing Director of FUJIFILM Europe.
"Thanks to this important acquisition, we have combined the strengths and skills of two leading companies in the sector, and today we offer a package of comprehensive and cutting-edge solutions. Fujifilm is now a company that offers a more comprehensive portfolio to healthcare providers across Europe. New milestones await us in AI, Healthcare IT, CT, MRI, ultrasound and many more fields, intending to create new values of excellence across this exciting new combined team," adds Masaharu Fukumoto, Senior Vice President, FUJIFILM Europe.
"We bring to Fujifilm many decades of experience in the market, alongside a strong and comprehensive product portfolio. The two organisations complement each other perfectly, and I am excited for the service and support we can offer together with a new combined team that is ready to embrace new challenges and great adventures in the future. Together we are stronger," said Jean-Luc Budillon, President and COO, FUJIFILM Healthcare Europe.
About Fujifilm in Europe
Fujifilm operates over 50 group companies and branches in Europe and employs approximately 4,500 people engaged in R&D, manufacturing, sales and service, with FUJIFILM Europe GmbH, located in Düsseldorf, Germany, operating as the strategic headquarters for the region. Throughout Europe, Fujifilm entities serve a range of industries including medical technology, biopharmaceuticals, electronic materials, industrial products, chemicals, graphic systems, optical devices, data storage and all aspects of photography. Over the last 20 years, the company has more intensively focused on healthcare - from diagnosis to prevention and treatment. Today, Fujifilm in Europe provides the entire spectrum of patient care, in addition to research, development and manufacturing in advanced therapies, gene therapies and vaccines, as well as providing cell culture media and regenerative medicine solutions.
For more information, please visit: fujifilm.com
About FUJIFILM Holdings Corporation
FUJIFILM Holdings Corporation, located in Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the fiscal year ended March 31, 2021, the company had global revenues of Euro 16,7 billion, at an exchange rate of 131,6 yen to the Euro. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship.
For more information, please visit: holdings.fujifilm.com
Head of Corporate Communications – Europe
FUJIFILM Europe GmbH
Deputy Head of Corporate Communications – Europe
FUJIFILM Europe GmbH
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Sinch AB (publ): Sale of warrants from long term incentive program in Sinch AB (publ)29.7.2021 18:15:00 CEST | Press release
Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH Sinch AB (publ), a global leader in cloud communications for mobile customer engagement, today announces that the company’s CEO, and other persons discharging managerial responsibilities, have divested warrants related to the long term incentive program LTI 2018. The LTI 2018 incentive program was adopted by the AGM on 18 May 2018 and consists of six different series. Series 1-3 consists of warrants for which Sinch AB received an upfront, cash payment from each program participant. Series 4-6 consists of employee stock options which employees are awarded over time, and where no monetary consideration is paid to Sinch. Each warrant and stock option allows the holder to acquire 10 shares in Sinch. The warrants and stock options have a duration of three to five years, with exercise periods in 2021, 2022 and 2023. In accordance with the European Market Abuse Regulation (MAR), transactions by CEO Oscar Werner and other persons discharging ma
Sinch AB (publ): Försäljning av teckningsoptioner från incitamentsprogram i Sinch AB (publ)29.7.2021 18:15:00 CEST | Pressemelding
Pressmeddelande Stockholm, Sverige – Sinch AB (publ) – XSTO: SINCH Sinch AB (publ), en ledande global leverantör av molntjänster för kundinteraktion via mobilen, meddelar idag att vd och andra ledande befattningshavare har sålt teckningsoptioner i Sinch kopplat till incitamentsprogrammet LTI 2018. Incitamentsprogrammet LTI 2018 beslutades av bolagsstämman i Sinch den 18 maj 2018 och består av sex olika serier. Serie 1-3 består av teckningsoptioner som Sinch AB överlåtit till anställda mot kontant ersättning. Serie 4-6 består av personaloptioner som anställda erhåller över tid som löneförmån. Varje option ger rätt att teckna tio aktier. Optionerna löper över tre till fem år med förfall 2021, 2022 och 2023. I enlighet med den europeiska marknadsmissbruksförordningen (MAR) har transaktioner för vd Oscar Werner och övriga ledande befattningshavare registrerats i Finansinspektionens insynsregister. Dessa transaktioner gäller försäljning av teckningsoptioner i serie 1. För vd Oscar Werner ra
FLSmidth to acquire thyssenkrupp’s Mining business – creating a global industry leader in mining technology29.7.2021 12:39:04 CEST | Press release
Company Announcement No. 7 2021 FLSmidth and thyssenkrupp Industrial Solutions AG (a fully owned subsidiary of thyssenkrupp AG, "thyssenkrupp") have reached an agreement that FLSmidth will acquire thyssenkrupp’s Mining business1 (TK Mining) for a total consideration (enterprise value) of EUR 325 million, corresponding to approximately DKK 2.4 billion. Closing of the transaction is expected in H2 2022 and is subject to customary approvals from relevant authorities. TK Mining is a leading full-line supplier of solutions for mining systems, material handling, mineral processing and services, which is highly complementary to FLSmidth’s offering. TK Mining has an asset light business model and is present in 24 countries with engineering and global service centres, and has close to 3,400 employees. In 20202, revenue was EUR 780 million (approximately DKK 5.8 billion) with around one-third deriving from services. The business delivered a high single-digit negative EBIT margin and is expected
Millicom to repurchase own shares29.7.2021 12:02:00 CEST | Press release
Millicom to repurchase own shares Luxembourg, July 29, 2021 – On May 4, 2021, the Annual General Meeting of Shareholders (“AGM”) of Millicom resolved to authorize (the “Authorization”) the Board of Directors of Millicom (the “Board”) to adopt a share repurchase plan. Based on the Authorization, the Board has decided to initiate a repurchase program comprising not more than 5,000,000 Swedish Depository Receipts representing the Company’s ordinary shares (“SDRs”). The purposes of the share repurchase plan may include: reduction of Millicom's share capital; meeting obligations for Board remuneration; and/or meeting obligations under Millicom’s share-based incentive plans or other compensation programs. The repurchase program will be implemented in accordance with the Authorization, the Nasdaq Nordic Main Market Rulebook for Issuers of Shares (“Nasdaq Rulebook”), and applicable law including the Luxembourg law of 10 August 1915 on commercial companies, as amended, and the EU Market Abuse R
Fobi Wallet Pass For Ticketing And Global Fan Engagement Powers bdG Sports “Baha Mar Hoops” Tournament Featuring 19 NCAA Men’s And Women’s Basketball Teams, Including US Thanksgiving Nationally Televised Events29.7.2021 12:00:00 CEST | Press release
After multiple event successes with bdG Sports, Fobi is now adding ticketing and admissions capabilities to live and digital fan engagement to deliver a comprehensive solution for the “largest early season event in all of college basketball” at Baha Mar Hoops in The Bahamas VANCOUVER, British Columbia., July 29, 2021 (GLOBE NEWSWIRE) -- Fobi AI Inc. (formerly Loop Insights Inc.) (TSXV: FOBI) (OTCQB: FOBIF) (the "Company" or "Fobi"), is pleased to announce it will once again be supporting bdG Sports for college basketball’s largest early season event. The invite-only global event at Baha Mar Convention Center in Nassau, The Bahamas will take place from November 22-27, 2021 and will use Fobi’s Wallet Pass platform for ticketing, admission, and fan engagement both live and at home. Fobi will earn significant revenue from this event through the event license, ticket fees and fan activations both live and at home, including nationally televised and digital audiences across the United States
Building momentum and delivering results29.7.2021 12:00:00 CEST | Press release
Building momentum and delivering results Luxembourg, July29, 2021– Millicom is pleased to announce its second quarter 2021 results. Please find below links to the Q2 2021 Earnings Release and H1 2021 Interim Condensed Consolidated Financial Statements. Millicom Chief Executive Officer Mauricio Ramos commented: "We had an outstanding Q2. We built on our robust Q1 performance and delivered double-digit growth in both service revenue and EBITDA. In Colombia, we now have the best mobile network, and we capitalized on this in Q2 by leading the market in portability and by adding a record number of new postpaid customers. Our rapid customer and revenue growth is a direct result of our unwavering commitment to delivering the best customer experience, including network quality and reliability. With that in mind, and considering our healthy cash flow generation, we have accelerated investments that we expect will help us drive faster growth in all our businesses going forward. In light of our s
Summary of AB Klaipedos nafta webinar29.7.2021 11:30:00 CEST | Press release
On the 29th July 2021, AB Klaipedos nafta (KN) held an investor conference webinar where KN Chief Executive Officer Darius Šilenskis and acting Chief Financial Officer Indrė Kisielienė commented Company’s financial results for the six months of 2021. Webinar recording is available online at: https://youtu.be/BmHfUpOVmEM The presentation demonstrated during the webinar is attached to this announcement. Indrė Kisielienė, Acting Chief Financial Officer, +370 686 16276 Attachment KN_activity results for_2021_Q2